Daily FNArena News - Australia

Seasonal headwinds confront agricultural chemical supplier Nufarm in some jurisdictions but several brokers retain a positive view based on acquisitions and cost savings.

Impressive growth achieved in 2017 leaves analysts positive and enthusiastic about Appen’s growth potential on the back of a global boom in artificial intelligence.

FNArena’s Reporting Season Monitor keeps track of the previous session’s corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

Heightened costs in transitioning the Mondelez Grocery business have muddied the outlook for Bega Cheese in FY18/19.

FNArena’s Reporting Season Monitor keeps track of the previous session’s corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

FNArena’s Reporting Season Monitor keeps track of the previous session’s corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

FNArena’s Reporting Season Monitor keeps track of the previous session’s corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.

Weaker demand at Australian hospitals has affected Ramsay Health Care and broker opinions diverge on the strength of the outlook.

Caltex has outlined significant changes to retail operations, expected to deliver 10-15% growth in earnings within five years.

FNArena’s Reporting Season Monitor keeps track of the previous session’s corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments.